Nano-Rifabutin entrapment within glucan microparticles enhances protection against intracellular Mycobacterium tuberculosis

References

• World Health Organization Global Tuberculosis Control Report. 2017. Available from: https://www.who.int/gho/tb/epidemic/cases_deaths/en/
   Google Scholar
• D'Ambrosio L, Centis R, Tiberi S, et al. Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review. J Thorac Dis. 2017;9:2093–2101.
   PubMed Web of Science ®Google Scholar
• Hoffmann H, Kohl TA, Hofmann-Thiel S, et al. Delamanid and bedaquiline resistance in Mycobacterium tuberculosis ancestral Beijing genotype causing extensively drug-resistant tuberculosis in a Tibetan refugee. Am J Respir Crit Care Med. 2016;193:337–340.
   PubMed Web of Science ®Google Scholar
• Ehrt S, Schnappinger D. Mycobacterial survival strategies in the phagosome: defense against host stresses. Cell Microbiol. 2009;11:1170–1178.
   PubMed Web of Science ®Google Scholar
• Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 2009;7:355–366.
   PubMed Web of Science ®Google Scholar
• Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 1994;263:678–681.
   PubMed Web of Science ®Google Scholar
• Hestvik ALK, Hmama Z, Av-Gay Y. Mycobacterial manipulation of the host cell. FEMS Microbiol Rev. 2005;29:1041–1050.
   PubMed Web of Science ®Google Scholar
• Kahnert A, Seiler P, Stein M, et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol. 2006;36:631–647.
   PubMed Web of Science ®Google Scholar
• Prior S, Gander B, Blarer N, et al. In vitro phagocytosis and monocyte–macrophage activation with poly (lactide) and poly (lactide-co-glycolide) microspheres. Eur J Pharm Sci. 2002;15:197–207.
   PubMed Web of Science ®Google Scholar
• Sharma R, Muttil P, Yadav AB, et al. Uptake of inhalable microparticles affects defense responses of macrophages infected with Mycobacterium tuberculosis H37Ra. J Antimicr Chemother. 2007;59:499–506.
   PubMed Web of Science ®Google Scholar
• Yadav AB, Misra A. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity. Antimicrob Agents Chemother. 2007;51:3740–3742.
   PubMed Web of Science ®Google Scholar
• Soto ER, Caras AC, Kut LC, et al. Glucan particles for macrophage targeted delivery of nanoparticles. J. Drug Deliv. 2012;2012:1.
   Google Scholar
• Soto ER, Kim YS, Lee J, et al. Glucan particle encapsulated rifampicin for targeted delivery to macrophages. Polymers. 2010;2:681–689.
   Web of Science ®Google Scholar
• Upadhyay TK, Fatima N, Sharma D, et al. Preparation and characterization of beta-glucan particles containing a payload of nano-embedded rifabutin for enhanced targeted delivery to macrophages. Excli J. 2017;7:210–228.
   Google Scholar
• Soto ER, O’Connell O, Dikengil F, et al. Targeted delivery of glucan particle encapsulated gallium nanoparticles inhibits HIV growth in human macrophages. J Drug Deliv. 2016;2016:1.
   Web of Science ®Google Scholar
• Bass DA, Parce JW, Dechatelet LR, et al. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910–1917.
   PubMed Web of Science ®Google Scholar
• Scott JA, Homcy CJ, Khaw BA, et al. Quantitation of intracellular oxidation in a renal epithelial cell line. Free Radic Biol Med. 1988;4:79–83.
   PubMed Web of Science ®Google Scholar
• Jamaati H, Mortaz E, Pajouhi Z, et al. Nitric oxide in the pathogenesis and treatment of tuberculosis. Front Microbiol. 2017;8:2008–2008.
   PubMed Web of Science ®Google Scholar
• Jang SA, Park SK, Lim JD, et al. The comparative immunomodulatory effects of β-glucans from yeast, bacteria, and mushroom on the function of macrophages. Jfn. 2009;14:102–108.
   Google Scholar
• Ahamad MS, Siddiqui S, Jafri A, et al. Induction of apoptosis and anti-proliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One. 2014;9:e110003.
   PubMed Web of Science ®Google Scholar
• Lewandowska U, Szewczyk K, Owczarek K, et al. Flavanols from evening primrose (Oenothera paradoxa) defatted seeds inhibit prostate cells invasiveness and cause changes in Bcl-2/Bax mRNA ratio. J Agric Food Chem. 2013;61:2987–2998.
   PubMed Web of Science ®Google Scholar
• Kumari A, Kakkar P. Lupeol protects against acetaminophen-induced oxidative stress and cell death in rat primary hepatocytes. Food Chem Toxicol. 2012;50:1781–1789.
   PubMed Web of Science ®Google Scholar
• Veena VK, Popavath RN, Kennedy K, et al. In vitro antiproliferative, pro-apoptotic, antimetastatic and anti-inflammatory potential of 2,4-diacetylphloroglucinol (DAPG) by Pseudomonas aeruginosa strain FP10. Apoptosis. 2015;20:1281–1295.
   PubMed Web of Science ®Google Scholar
• Fatima N, Upadhyay T, Sharma D, et al. Particulate beta-glucan induces early and late phagosomal maturation in murine macrophages. Front Biosci (Elite Ed). 2017;9:129–140.
   PubMedGoogle Scholar
• Van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev. 2002;15:294–309.
   PubMed Web of Science ®Google Scholar
• Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev. 2015;264:182–203.
   PubMed Web of Science ®Google Scholar
• Lerner TR, Borel S, Gutierrez MG. The innate immune response in human tuberculosis. Cell Microbiol. 2015;17:1277–1285.
   PubMed Web of Science ®Google Scholar
• Attwood EM, Weich DJV, Oosthuizen JMC. Influence of carbon particles on superoxide and hydrogen peroxide radical release during the killing of Mycobacterium bovis by alveolar macrophages. Tuber Lung Dis. 1996;77:462–467.
   PubMedGoogle Scholar
• Yadav AB, Sharma R, Muttil P, et al. Inhalable microparticles containing isoniazid and rifabutin target macrophages and “stimulate the phagocyte” to achieve high efficacy. Indian J Exp Biol. 2009;47:469–474.
   PubMed Web of Science ®Google Scholar
• MacMicking JD, North RJ, LaCourse R, et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA. 1997;94:5243–5248.
   PubMed Web of Science ®Google Scholar
• Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175–195.
   PubMed Web of Science ®Google Scholar
• Chan J, Xing Y, Magliozzo RS, et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992;175:1111–1122.
   PubMed Web of Science ®Google Scholar
• Voskuil MI, Bartek IL, Visconti K, et al. The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol. 2011;2:105.
   PubMed Web of Science ®Google Scholar
• Robinson JM. Phagocytic leukocytes and reactive oxygen species. Histochem Cell Biol. 2009;131:465–469.
   PubMed Web of Science ®Google Scholar
• Cooper AM, Segal BH, Frank AA, et al. Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. Infect Immun. 2000;68:1231–1234.
   PubMed Web of Science ®Google Scholar
• Yang CS, Shin DM, Kim HK, et al. NADPH Oxidase 2 interaction with TLR2 is required for efficient innate immune responses to Mycobacteria via Cathelicidin expression. J Immunol. 2009;182:3696–3705.
   PubMed Web of Science ®Google Scholar
• Vergne I, Chua J, Singh SB, et al. Cell biology of Mycobacterium tuberculosis phagosome. Annu Rev Cell Dev Biol. 2004;20:367–394.
   PubMed Web of Science ®Google Scholar
• Rohde K, Yates RM, Purdy GE, et al. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev. 2007;219:37–54.
   PubMed Web of Science ®Google Scholar
• Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753–766.
   PubMed Web of Science ®Google Scholar
• Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol. 2005;26:523–528.
   PubMed Web of Science ®Google Scholar
• Deretic V. Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol. 2012;24:21–31.
   PubMed Web of Science ®Google Scholar
• Gan H, Lee J, Ren F, et al. Mycobacterium tuberculosis blocks cross linking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol. 2008;9:1189–1197.
   PubMed Web of Science ®Google Scholar
• Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol. 2010;8:668–674.
   PubMed Web of Science ®Google Scholar
• Gil D, Garcia LF, Rojas M. Modulation of macrophage apoptosis by antimycobacterial therapy: physiological role of apoptosis in the control of Mycobacterium tuberculosis. Tox Appl Pharmacol. 2003;190:111–119.
   PubMed Web of Science ®Google Scholar
• Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45:528–537.
   PubMed Web of Science ®Google Scholar
• Lawlor C, O’Connor G, O’Leary S, et al. Treatment of Mycobacterium tuberculosis-infected macrophages with poly (lactic-co-glycolic acid) microparticles drives NF kappa B and autophagy dependent bacillary killing. PLoS One. 2016;11:e0149167.
   PubMed Web of Science ®Google Scholar
• Kalluru R, Fenaroli F, Westmoreland D, et al. Polylactide-co-glycolide-rifampicin-nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes. J Cell Sci. 2013;126:3043–3054.
   PubMed Web of Science ®Google Scholar
• Akramiene D, Kondrotas A, Didziapetriene J, et al. Effects of beta-glucans on the immune system. Medicina (Kaunas). 2007;43:597–606.
   PubMed Web of Science ®Google Scholar
• Chan GCF, Chan WK, Y Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009;2:25.
   PubMed Web of Science ®Google Scholar
• Novak M, Vetvicka V. Glucans as biological response modifiers. Emiddt. 2009;9:67–75.
   Google Scholar
• Hunter KW, Gault RA, Berner MD. Preparation of microparticulate beta-glucan from Saccharomyces cerevisiae for use in immune potentiation. Lett Appl Microbiol. 2002;35:267–271.
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of L‐lactic acid/glycolic acid homo‐and copolymers. J Biomed Mater Res. 1988;22:837–858.
   PubMed Web of Science ®Google Scholar
• Schepetkin IA, Quinn MT. Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int J Immunopharmacol. 2006;6:317–333.
   PubMed Web of Science ®Google Scholar